TA Associates agrees to acquire majority stake in MedEnvision

• TA Associates will acquire a majority stake in Belgian medtech company MedEnvision, alongside its founders, management and existing investor Smile Invest.
• The transaction is expected to close in the fourth quarter of 2026, subject to closing conditions.
• The investment will support international expansion, particularly in the US, broader product offerings and commercial development.
• MedEnvision provides operating-room efficiency solutions for orthopedic surgery in more than 26 countries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TA Associates Management LP published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.